Application of Artificial Intelligence in Early Detection of Eye Complications in Diabetics
NCT ID: NCT05655117
Last Updated: 2022-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
440 participants
INTERVENTIONAL
2023-01-31
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To what extent does the application of artificial intelligence-based eye care at primary care clinics work well in achieving early detection of eye complications such as macular oedema? To what extent does the application of artificial intelligence-based eye care at primary care clinics work well in achieving early detection of eye complications such as retinopathy? Participants will be asked to participate in the screening for eye complications at primary care centres, and a fundus camera will be used for screening.
Researchers will compare the proportion of detected cases with early signs of eye complication among those using artificial intelligence-based eye screening i.e., fundus camera, to the proportion of detected cases among those using routine eye care clinics at the primary care centre.
Early detection of eye complications in diabetics prevents the risk of blindness.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Due to low operation, AI could be used in the early detection and screening of diabetic retinopathy by application of the service across a mass population and resource-limited areas with a scarcity of eye care services.
AI-based eye care in terms of screening for diabetic retinopathy will make the screening process more effective and cheap and could be delegated to technicians, practitioners, and/or even home-based self-screening.
Recognizing the high prevalence of type 2 diabetes mellitus (T2DM) among adults, the use of a nonmydriatic fundus camera with AI is effective in eye exams as it improves adult adherence to eye screening.
The primary aim of the trial will be to assess the effectiveness of the application of AI devices in terms of fundus cameras in the early detection of diabetic retinopathy and macular oedema among diabetic patients attending primary care centres.
Research Questions:
To what extent does the application of artificial intelligence-based eye care at primary care centre is effective in achieving a high detection rate of macular oedema? To what extent does the application of artificial intelligence-based eye care at primary care clinic is effective in achieving a high detection rate of retinopathy?
General objective:
To estimate the effectiveness of applying AI-based eye care at primary care centres in achieving a high detection rate of macular oedema and retinopathy among diabetics.
Specific Objectives:
Aim 1: To compare the proportion of detected cases of macular oedema in the intervention versus the control group (routine eye care) attending the primary care centre.
Aim 2: To compare the proportion of detected cases of retinopathy in the intervention versus the control group (routine eye care) attending the primary care centre
Literature Review:
Although recent models had been suggested for implementing digital health solutions like stream fishing, inflow funnel, pyramid, and shuffling cards that represent options for clinical services with progressively increasing capacity and willingness to operationalize digital health.
However, various challenges are facing the deployment of AI, telehealth, and the internet of things (IoT) worldwide. Barriers to adopting these digital health solutions are many and could be inferred to infrastructure, the quality of the device, common willingness, and legal aspects.
Evidence revealed that using Macustat retina function scan AI in remote monitoring of a patient with age-related macular oedema or diabetic retinopathy has a great impact on patient health.
Research Design and Methods:
This is a six months clustered randomized trial that will recruit patients with type II diabetes who are attending primary eye care clinics at primary care centres in Hail city.
Participants (P):
The participants will be type II diabetic patients of both genders attending the selected primary care centres irrespective of their duration of disease and the types of medication currently received. The participants are expected to be adults aged 18 years and above. Children and young adults with juvenile diabetes mellitus will be excluded. In addition, severely ill patients, and patients with mental disorders will be excluded. The participants will be assessed at the start to collect the baseline data about diabetic retinopathy and macular oedema using AI devices to report detected cases. At the end of the trial, a similar report of detected cases will be obtained three and six months after the beginning of the trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AI-based screening for early detection of diabetic retinopathy and macular Oedema
The application of AI devices i.e Fundus Camera to detect diabetic retinopathy and macular Oedema in diabetics at the primary care centre
AI based eye screening
The application of AI devices i.e Fundus Camera to detect diabetic retinopathy and macular Oedema in diabetics at the primary care centre
Routine screening for diabetic retinopathy and macular oedema
The Routine screening for diabetic retinopathy and macular oedema in diabetics during a routine visit to an eye care clinic at the primary care centre.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AI based eye screening
The application of AI devices i.e Fundus Camera to detect diabetic retinopathy and macular Oedema in diabetics at the primary care centre
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Health Holding Company, Hail Health Cluster
UNKNOWN
The New Model of Care, Hail Health Cluster
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Khalil Alshammari, VIP Chief MO
Role: STUDY_CHAIR
Hail Health Cluster
Fakhralddin Elfakki, Researcher at MOC
Role: PRINCIPAL_INVESTIGATOR
New Model of Care, Hail Health Cluser
Meshari Aljamani, MOC Lead
Role: STUDY_DIRECTOR
New Model of Care, Hail Health Cluster
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Model of Care Hail Cluster
Identifier Type: -
Identifier Source: org_study_id